Clinical Trial Update: A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults [Phase 3]

View source ↗

Summary

Phase 3 bridging study comparing two lots of Sci-B-Vac and Engerix-B in healthy adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• Sci-B-Vac (hepatitis B vaccine (recombinant))

Snippet

Sponsor: VBI Vaccines Inc. | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2022-06-24